Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT06906471

A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

Conditions: Prostate Cancer, Prostate Cancer (Adenocarcinoma), Fluorescence Imaging

Sex: Male
Ages: 18 Years – 90 Years
Healthy volunteers: No
Phase: PHASE1, PHASE2
Enrollment: 10
Sponsor: Antelope Surgical Solutions, Inc

Location: HCA Florida Kendall Hospital Miami Florida

Summary

A Single-Arm, blinded, fluorescent PSMA histopathology trial of AS1986NS

Eligibility Criteria

Inclusion Criteria: * suspected prostate cancer warranting standard of care multi-core prostate biopsy Exclusion Criteria: * Patients receiving same-day therapeutic Lutetium-177 or Actinium-225 PSMA receptor radiation isotope therapy treatment * Patients with pre-existing, impaired or abnormal hepatic function, renal function, cardiac function, and abnormal elevated temperature * Patients with a creatinine clearance cutoff (CrCl) of \< 60 mL/min

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06906471). StuddyBuddy aggregates publicly available trial information.